3E0BXTZ
3E0BXTZ — Introduction of Destructive Agent into Ear, External Approach
Billable / specific codeICD-10-PCS
CMS abbreviated title: Introduction of Destructive Agent into Ear, Extern Approach
How 3E0BXTZ is built
Every ICD-10-PCS code is seven independent character positions. Each one is a separate decision, and the meaning of a character depends on the positions before it.
- 3SectionAdministration — What family of procedure this is
- EBody systemWhich system it acts on
- 0Root operationThe objective — the verb of the procedure
- BBody partThe specific site
- XApproachHow the site was reached
- TDeviceWhat was left in place, if anything
- ZQualifierA further distinction where one applies
Codes near 3E0BXTZ
In CMS’s own ordering, which groups codes that differ by only the last character or two — usually the approach, device or qualifier.
- 3E0BX28Introduction of Oxazolidinones into Ear, External Approach
- 3E0BX29Introduction of Other Anti-infective into Ear, External Approach
- 3E0BX3ZIntroduction of Anti-inflammatory into Ear, External Approach
- 3E0BXBZIntroduction of Anesthetic Agent into Ear, External Approach
- 3E0BXGCIntroduction of Other Therapeutic Substance into Ear, External Approach
- 3E0BXHZIntroduction of Radioactive Substance into Ear, External Approach
- 3E0BXKZIntroduction of Other Diagnostic Substance into Ear, External Approach
- 3E0BXNZIntroduction of Analgesics, Hypnotics, Sedatives into Ear, External Approach
- 3E0BXTZIntroduction of Destructive Agent into Ear, External Approach
- 3E0C304Introduction of Liquid Brachytherapy Radioisotope into Eye, Percutaneous Approach
- 3E0C305Introduction of Other Antineoplastic into Eye, Percutaneous Approach
- 3E0C30MIntroduction of Antineoplastic, Monoclonal Antibody, into Eye, Percutaneous Approach
- 3E0C328Introduction of Oxazolidinones into Eye, Percutaneous Approach
- 3E0C329Introduction of Other Anti-infective into Eye, Percutaneous Approach
- 3E0C33ZIntroduction of Anti-inflammatory into Eye, Percutaneous Approach
- 3E0C3BZIntroduction of Anesthetic Agent into Eye, Percutaneous Approach
- 3E0C3GCIntroduction of Other Therapeutic Substance into Eye, Percutaneous Approach